ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620256 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620256; 2) Community: the network communities that were significantly associated with the response to NSC 620256; 3) Molecule: the relationships between components within communities and NSC 620256; 4) MDR: the compounds that were significantly associated with the NSC 620256.

NSC Compound Enrichment Correlation
NSC 374028 Camptothecin Derivative 0.00140570135773563 0.42744872
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.00140570135773563 0.26884414
NSC 741459 (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 0.00159809164939554 0.45601271
NSC 759263 Topotecan hydrochloride (USAN) 0.00163780067775768 0.38362913
NSC 681642 Camptothecin Derivative 0.00165587325865809 0.46507227
NSC 349174 Oxanthrazole 0.0016558732586581 0.62086407
NSC 355644 Anthrapyrazole derivative 0.0016558732586581 0.62073379
NSC 736198 Indenoisoquinoline derivative 0.00165587325865811 0.4291459
NSC 626390 Null 0.00174331675630443 0.10397566
NSC 733504 Everolimus 0.00174331675630443 0.083083205
Total:49  Current:2    [First] [Prev] [Next] [Last]